On Wednesday, we’ll get to see earnings out of Biogen Idec Inc. (NASDAQ: BIIB). The estimates from First Call for the biotech company are $0.80 EPS on $835.16 million in ... Read Full Story »
Genentech (NYSE:DNA) posted $0.73 EPS vs $0.72 estimates, but revenues were $2.95 Billion versus a $2.93 Billion estimate. It looks like 3 of the 4 major drugs came in under ... Read Full Story »
Genentech Inc. (NYSE:DNA) is set to report earnings after today's close. First Call has consensus estimates at $0.72 EPS on $2.93 Billion in revenues. The biotech giant usually offers guidance ... Read Full Story »